摘要
目的探讨液基细胞学制片技术在早期宫颈癌筛查中的价值。方法2005年9月-2006年9月应用液基细胞学制片技术对572例患者进行细胞学检查。结果572例患者取材均为满意涂片。按照国际进行的TBS分类标准分类,检出异常结果有:意义不明的非典型鳞状上皮细胞(ASC-US)12例,不能排除高度病变的非典型鳞状上皮细胞(ASC-H)1例,低度鳞状上皮内病变(LSLL)1例,宫颈鳞癌(SCC)1例。结论液基细胞学制片技术早期宫颈癌的防治有积极的作用。
Discussion of thinprep cytologic test (TCT)in the value of prevention and treatment of cervical cancer [Mathods] September 2005 to September 2006 application TCT producer technology 572 cases of patients with cytological examination. [Results] 572 cases of patients were satisfied with the smear The Bethesda system (TBS) conducted in accordance with international classification standard classifications and the detection abnormal results are:not clear, significance unknown atypical squamous cell (ASCUS) 12cases, the disease can not be ruled out highly atypical squamous cell (ASCUH) 1 cases, low squamous intraepithelial lesions (LSIL) 1 cases, cervical squamous cell carcinoma 1 cases [conclusion] thinprep cytologic test (TCT) for cervical cancer producers technology plays a positive role in prevention and treatment.
出处
《泰州职业技术学院学报》
2007年第6期68-70,共3页
Journal of Taizhou Polytechnic College
关键词
细胞学技术
宫颈癌
液基细胞技术
cytologic test
cervical cencer
thinprep cytologic tset